From the U.S. Food & Drug Administration
Irbesartan Tablets
Sciegen Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Irbesartan Tablets, USP 75 Mg, 150 Mg, and 300 Mg Due to The Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine) Impurity Found in The Active Pharmaceutical Ingredient (API)
See FDA https://www.fda.gov/Safety/Recalls/ucm624593.htm
______________________________
Prednisolone and Gatifloxacin Ophthalmic Solution
Promise Pharmacy Issues Voluntary Nationwide Recall of Prednisolone and Gatifloxacin Ophthalmic Solution 1%/0.5% Sterile Due to Small Particulate Floating in the Solution
See FDA https://www.fda.gov/Safety/Recalls/ucm623994.htm
